Justine H.
- Country
- Belgium
- Department
- Nephrology-Dialysis-Hypertension
Research Overview
- Evaluation of Baxdrostat and Dapagliflozin on Chronic Kidney Disease Progression in Hypertensive Patients: A Randomized, Double-Blind, Active-Controlled Phase III Trial
- Efficacy and Safety Evaluation of Baxdrostat in Patients with Uncontrolled and Resistant Hypertension on Multidrug Regimens: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 24 of 241 partner sites.
Specializations
Cardiovascular Research
The investigator specializes in studying treatments for uncontrolled hypertension and resistant hypertension, particularly focusing on patients whose blood pressure remains elevated despite conventional therapeutic approaches.
- Blood Pressure Management
- Treatment-Resistant Cases
- Multiple Drug Therapy
Research extends to evaluating novel therapeutic agents for patients who do not achieve optimal blood pressure control with standard treatments.
Nephrology Studies
The investigator conducts research in chronic kidney disease (CKD) management, with particular attention to its relationship with hypertension and innovative therapeutic combinations.
- Kidney Disease Progression
- Renal Function Assessment
- Combined Therapeutic Approaches
Investigation focuses on therapeutic strategies to slow the progression of kidney disease while managing associated cardiovascular complications.
Treatment Innovation
The investigator explores novel therapeutic combinations for complex medical conditions, particularly focusing on cases where conventional treatments prove insufficient.
- Combination Therapy Evaluation
- Treatment Efficacy Assessment
- Safety Profile Analysis
Research emphasizes the development of innovative treatment approaches for patients with concurrent cardiovascular and renal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.